Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6524368 | 0.88 | NPC1 (0.36) | POLBCYP2C19ALDH1A1LMNAMEN1 | |
| SCHEMBL6518839 | 0.85 | TSHR (0.41) | KCNN4POLBCYP2C19HIF1AALDH1A1 | |
| SCHEMBL6517368 | 0.84 | CYP19A1 (0.38) | CYP2C19HIF1AALDH1A1TSHRKMT2A | |
| SCHEMBL6520254 | 0.83 | CYP2C19 (0.41) | KCNN4POLBCYP2C19HIF1AALDH1A1 | |
| SCHEMBL11419767 | 0.83 | KCNN4 (0.53) | KCNN4POLBCYP2C19HIF1AALDH1A1 | |
| SCHEMBL6517058 | 0.81 | ALDH1A1 (0.47) | ALDH1A1LMNASMN1; SMN2KMT2A | |
| SCHEMBL6523105 | 0.81 | ALDH1A1 (0.40) | ALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL6522215 | 0.78 | MAPT (0.41) | POLBCYP2C19HIF1AALDH1A1TSHR | |
| SCHEMBL6522162 | 0.78 | KEAP1 (0.38) | ALDH1A1LMNA | |
| SCHEMBL6520850 | 0.78 | ALDH1A1 (0.38) | ALDH1A1LMNASMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | KCNN4 4107/4885POLB 2327/4885CYP2C19 2771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.